[Anxiety disorders: diagnosis and therapy from the family physician's perspective].
Anxiety disorders today are regarded as very treatable conditions, provided that pharmaco- and/or psychotherapy are implemented according to evidence-based guidelines. The family physician treats primarily with pharmaceutical preparations. For this, a series of antidepressants, mainly belonging to the SSRI and SNRI substance groups, are available. Among the psychotherapeutic methods, cognitive behavior and confrontation therapies have been proven successful.
Boerner
R J
RJ
Zentrum für integrative Diagnostik und Therapie von Angsterkrankungen, Christliches Krankenhaus e.V., Quakenbrück. r.boerner@christliches-krankenhaus-ev.de
D000928:Antidepressive Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005194:Family Practice; D006801:Humans; D016584:Panic Disorder / Q000175:diagnosis / Q000628:therapy; D017374:Paroxetine / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride